Nutritional therapy for hepatocellular carcinoma

被引:0
|
作者
Astrid Ruiz-Margáin [1 ,2 ]
Berenice M Román-Calleja [1 ]
Paulina Moreno-Guillén [1 ]
José A González-Regueiro [3 ]
Deyanira Kúsulas-Delint [3 ]
Alejandro Campos-Murguía [3 ]
Nayelli C Flores-García [3 ]
Ricardo Ulises Macías-Rodríguez [2 ,3 ]
机构
[1] Liver Nutrition Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
[2] Liver Fibrosis and Nutrition Lab, MICTLáN-Network (Mechanisms of Liver Injury, Cell Death and Translational Nutrition in Liver Diseases-Research Network)
[3] Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤]; R459.3 [饮食疗法、临床营养学];
学科分类号
100214 ; 100215 ;
摘要
Hepatocellular carcinoma(HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking(generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosisrelated complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouragedand adapted to individual needs.
引用
收藏
页码:1440 / 1452
页数:13
相关论文
共 50 条
  • [21] Therapy in Advanced Hepatocellular Carcinoma
    Javan, Hanna
    Dayyani, Farshid
    Abi-Jaoudeh, Nadine
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2020, 37 (05) : 466 - 474
  • [22] Locoregional Therapy for Hepatocellular Carcinoma
    Kudo, M.
    LIVER CANCER, 2015, 4 (03) : 163 - 164
  • [23] Diagnosis of and Therapy for Hepatocellular Carcinoma
    Greten, T. F.
    Malek, N. P.
    Schmidt, S.
    Arends, J.
    Bartenstein, P.
    Bechstein, W.
    Bernatik, T.
    Bitzer, M.
    Chavan, A.
    Dollinger, M.
    Domagk, D.
    Drognitz, O.
    Duex, M.
    Farkas, S.
    Folprecht, G.
    Galle, P.
    Geissler, M.
    Gerken, G.
    Habermehl, D.
    Helmberger, T.
    Herfarth, K.
    Hoffmann, R. T.
    Holtmann, M.
    Huppert, P.
    Jakobs, T.
    Keller, M.
    Klempnauer, J.
    Kolligs, F.
    Koerber, J.
    Lang, H.
    Lehner, F.
    Lordick, F.
    Lubienski, A.
    Manns, M. P.
    Mahnken, A.
    Moehler, M.
    Moench, C.
    Neuhaus, P.
    Niederau, C.
    Ocker, M.
    Otto, G.
    Pereira, P.
    Pott, G.
    Riemer, J.
    Ringe, K.
    Ritterbusch, U.
    Rummeny, E.
    Schirmacher, P.
    Schlitt, H. J.
    Schlottmann, K.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (11): : 1269 - 1326
  • [24] Locoregional Therapy for Hepatocellular Carcinoma
    Guimaraes, Marcelo
    Uflacker, Renan
    CLINICS IN LIVER DISEASE, 2011, 15 (02) : 395 - +
  • [25] Frontiers of therapy for hepatocellular carcinoma
    Heller, Michael
    Parikh, Neehar D.
    Fidelman, Nicholas
    Owen, Dawn
    ABDOMINAL RADIOLOGY, 2021, 46 (08) : 3648 - 3659
  • [26] Operative therapy of hepatocellular carcinoma
    Farkas, S. A.
    Schlitt, H. J.
    RADIOLOGE, 2014, 54 (07): : 673 - 678
  • [27] Proton therapy for hepatocellular carcinoma
    Ted C.Ling
    Joseph I.Kang
    David A.Bush
    Jerry D.Slater
    Gary Y.Yang
    Chinese Journal of Cancer Research, 2012, 24 (04) : 361 - 367
  • [28] Radionuclide therapy for hepatocellular carcinoma
    Lambert, B.
    Van Vlierberghe, H.
    Troisi, R.
    Defreyne, L.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (04) : 484 - 488
  • [29] Systemic therapy for hepatocellular carcinoma
    McNamara, Mairead G.
    Knox, Jennifer J.
    HEPATIC ONCOLOGY, 2014, 1 (01) : 23 - 38
  • [30] Surgical therapy of hepatocellular carcinoma
    Strey, C. W.
    Zapletal, C.
    Bechstein, W. O.
    GASTROENTEROLOGE, 2007, 2 (01): : 20 - 26